Chris Toth

Chris Toth is chief executive officer at Vantive. 

In this role, Toth leads the company and its 23,000 employees to deliver on elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Toth leads the enterprise in pursuit of fulfilling the Vantive Mission of extending lives and expanding possibilities for patients and care teams everywhere. 

Toth was named CEO of Vantive upon the acquisition of Baxter Kidney Care by global investment firm Carlyle. 

Before joining Vantive, formerly Baxter Kidney Care, he served as chief executive officer of Varian, a Siemens Healthineers Company. Prior to this, he held numerous executive leadership roles across a two-decade career with Varian, including as president and chief operating officer; president of Varian Oncology Systems; and president of Global Commercial and Field Operations. 

Toth received a bachelor's degree in business administration with a concentration in marketing from the Lundquist College of Business at the University of Oregon. He also served as a member of the U.S. India Strategic Partnership Forum Board (USISPF) and the President’s Advisory Council for Doing Business in Africa (PACDBIA). He is currently on the Board of Directors for Moon Surgical.